Managing Biosimilars Is Like Herding Copycats
Developers and Regulators Are Attending to Naming Conventions and Equivalence Testing Assays
Top 10 Under 40
Biopharma Research and Businesses Benefit from Contributions of Emerging Leaders
The Scoop: St. Jude to Build a Collab-Fostering Research Hub
Ground Will Be Broken for a 625,000-Square-Foot Facility to Be Completed in 2021
Genomics Gets Personal
Despite Data and Privacy Challenges, Decreasing Cost Ushers in the Age of Personalized Whole-Genome Sequencing
For full access to this article login to GEN Select now.
Tumor Biomarkers Culled from Errant Transcripts
Potential for Blood Platelet–Derived Biomarkers to ID and Locate Tumors
- When cells go astray and stagger toward malignant fates, they leave behind the molecular equivalent of footprints. Some of the most telling footprints may be found along transcriptional pathways, but if the missteps are to be identified, they need to be distinguished from all the other molecular traces criss-crossing ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.